SYK and B-cell chronic lymphocytic leukemia: Entospletinib (GS-9973) is a novel selective Syk inhibitor that is being evaluated for its efficacy in treating hematopoietic malignancies like chronic lymphocytic leukemia (CLL), mantle cell lymphomas, acute myeloid leukemia (AML), etc. 49-51.